|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Mehlen P and Puisieux A: Metastasis: A
question of life or death. Nat Rev Cancer. 6:449–458. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Rosen PP: Rosen's Breast Pathology. 3rd.
LWW; pp. 171–242. 2008
|
|
4
|
Thompson A, Brennan K, Cox A, Gee J,
Harcourt D, Harris A, Harvie M, Holen I, Howell A, Nicholson R, et
al: Evaluation of the current knowledge limitations in breast
cancer research: A gap analysis. Breast Cancer Res. 10:R262008.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Vogelstein B, Papadopoulos N, Velculescu
VE, Zhou S, Diaz LA Jr and Kinzler KW: Cancer genome landscapes.
Science. 339:1546–1558. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Baylin SB and Jones PA: A decade of
exploring the cancer epigenome - biological and translational
implications. Nat Rev Cancer. 11:726–734. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Network CGA: Cancer Genome Atlas Network:
Comprehensive molecular portraits of human breast tumours. Nature.
490:61–70. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bissell MJ and Hines WC: Why don't we get
more cancer? A proposed role of the microenvironment in restraining
cancer progression. Nat Med. 17:320–329. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Semenza GL: Targeting HIF-1 for cancer
therapy. Nat Rev Cancer. 3:721–732. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Vaupel P, Höckel M and Mayer A: Detection
and characterization of tumor hypoxia using pO2 histography.
Antioxid Redox Signal. 9:1221–1235. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Vaupel P: Prognostic potential of the
pre-therapeutic tumor oxygenation status. Adv Exp Med Biol.
645:241–246. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Van den Beucken T, Koch E, Chu K,
Rupaimoole R, Prickaerts P, Adriaens M, Voncken JW, Harris AL,
Buffa FM, Haider S, et al: Hypoxia promotes stem cell phenotypes
and poor prognosis through epigenetic regulation of DICER. Nat
Commun. 5:52032014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Schindl M, Schoppmann SF, Samonigg H,
Hausmaninger H, Kwasny W, Gnant M, Jakesz R, Kubista E, Birner P
and Oberhuber G; Austrian Breast and Colorectal Cancer Study Group,
: Overexpression of hypoxia-inducible factor 1alpha is associated
with an unfavorable prognosis in lymph node-positive breast cancer.
Clin Cancer Res. 8:1831–1837. 2002.PubMed/NCBI
|
|
14
|
Samanta D, Gilkes DM, Chaturvedi P, Xiang
L and Semenza GL: Hypoxia-inducible factors are required for
chemotherapy resistance of breast cancer stem cells. Proc Natl Acad
Sci USA. 111:pp. E5429–E5438. 2014; View Article : Google Scholar : PubMed/NCBI
|
|
15
|
O'Reilly EA, Gubbins L, Sharma S, Tully R,
Guang MH, Weiner-Gorzel K, McCaffrey J, Harrison M, Furlong F, Kell
M, et al: The fate of chemoresistance in triple negative breast
cancer (TNBC). BBA Clin. 3:257–275. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hussain SA, Ganesan R, Reynolds G, Gross
L, Stevens A, Pastorek J, Murray PG, Perunovic B, Anwar MS,
Billingham L, et al: Hypoxia-regulated carbonic anhydrase IX
expression is associated with poor survival in patients with
invasive breast cancer. Br J Cancer. 96:104–109. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hiraga T, Kizaka-Kondoh S, Hirota K,
Hiraoka M and Yoneda T: Hypoxia and hypoxia-inducible factor-1
expression enhance osteolytic bone metastases of breast cancer.
Cancer Res. 67:4157–4163. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Semenza GL: Hypoxia-inducible factors in
physiology and medicine. Cell. 148:399–408. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kunz M and Ibrahim SM: Molecular responses
to hypoxia in tumor cells. Mol Cancer. 2:232003. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Potter C and Harris AL: Hypoxia inducible
carbonic anhydrase IX, marker of tumour hypoxia, survival pathway
and therapy target. Cell Cycle. 3:164–167. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Höckel M and Vaupel P: Tumor hypoxia:
Definitions and current clinical, biologic, and molecular aspects.
J Natl Cancer Inst. 93:266–276. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Al-Hajj M, Wicha MS, Benito-Hernandez A,
Morrison SJ and Clarke MF: Prospective identification of
tumorigenic breast cancer cells. Proc Natl Acad Sci USA. 100:pp.
3983–3988. 2003; View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ghebeh H, Sleiman GM, Manogaran PS,
Al-Mazrou A, Barhoush E, Al-Mohanna FH, Tulbah A, Al-Faqeeh K and
Adra CN: Profiling of normal and malignant breast tissue show
CD44high/CD24low phenotype as a predominant stem/progenitor marker
when used in combination with Ep-CAM/CD49f markers. BMC Cancer.
13:2892013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Dontu G, Abdallah WM, Foley JM, Jackson
KW, Clarke MF, Kawamura MJ and Wicha MS: In vitro propagation and
transcriptional profiling of human mammary stem/progenitor cells.
Genes Dev. 17:1253–1270. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Diaz-Guerra E, Lillo MA, Santamaria S and
Garcia-Sanz JA: Intrinsic cues and hormones control mouse mammary
epithelial tree size. FASEB J. 26:3844–3853. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Thiery JP: Epithelial-mesenchymal
transitions in tumour progression. Nat Rev Cancer. 2:442–454. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Blanco D, Vicent S, Elizegi E, Pino I,
Fraga MF, Esteller M, Saffiotti U, Lecanda F and Montuenga LM:
Altered expression of adhesion molecules and epithelial-mesenchymal
transition in silica-induced rat lung carcinogenesis. Lab Invest.
84:999–1012. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yoshida R, Kimura N, Harada Y and Ohuchi
N: The loss of E-cadherin, α- and β-catenin expression is
associated with metastasis and poor prognosis in invasive breast
cancer. Int J Oncol. 18:513–520. 2001.PubMed/NCBI
|
|
30
|
Friedl P and Wolf K: Tumour-cell invasion
and migration: Diversity and escape mechanisms. Nat Rev Cancer.
3:362–374. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Helczynska K, Kronblad A, Jögi A, Nilsson
E, Beckman S, Landberg G and Påhlman S: Hypoxia promotes a
dedifferentiated phenotype in ductal breast carcinoma in situ.
Cancer Res. 63:1441–1444. 2003.PubMed/NCBI
|
|
32
|
Bos R, Zhong H, Hanrahan CF, Mommers EC,
Semenza GL, Pinedo HM, Abeloff MD, Simons JW, van Diest PJ and van
der Wall E: Levels of hypoxia-inducible factor-1 alpha during
breast carcinogenesis. J Natl Cancer Inst. 93:309–314. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Koshiji M, Kageyama Y, Pete EA, Horikawa
I, Barrett JC and Huang LE: HIF-1alpha induces cell cycle arrest by
functionally counteracting Myc. EMBO J. 23:1949–1956. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhang H, Gao P, Fukuda R, Kumar G,
Krishnamachary B, Zeller KI, Dang CV and Semenza GL: HIF-1 inhibits
mitochondrial biogenesis and cellular respiration in VHL-deficient
renal cell carcinoma by repression of C-MYC activity. Cancer Cell.
11:407–420. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Schmidt EV: The role of c-myc in cellular
growth control. Oncogene. 18:2988–2996. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Amellem O, Löffler M and Pettersen EO:
Regulation of cell proliferation under extreme and moderate
hypoxia: The role of pyrimidine (deoxy)nucleotides. Br J Cancer.
70:857–866. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Hasvold G, Lund-Andersen C, Lando M,
Patzke S, Hauge S, Suo Z, Lyng H and Syljuåsen RG: Hypoxia-induced
alterations of G2 checkpoint regulators. Mol Oncol. 10:764–773.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Sullivan R, Paré GC, Frederiksen LJ,
Semenza GL and Graham CH: Hypoxia-induced resistance to anticancer
drugs is associated with decreased senescence and requires
hypoxia-inducible factor-1 activity. Mol Cancer Ther. 7:1961–1973.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Wouters A, Pauwels B, Lardon F and
Vermorken JB: Review: Implications of in vitro research on the
effect of radiotherapy and chemotherapy under hypoxic conditions.
Oncologist. 12:690–712. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Carmeliet P, Dor Y, Herbert JM, Fukumura
D, Brusselmans K, Dewerchin M, Neeman M, Bono F, Abramovitch R,
Maxwell P, et al: Role of HIF-1alpha in hypoxia-mediated apoptosis,
cell proliferation and tumour angiogenesis. Nature. 394:485–490.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Volm M and Koomägi R: Hypoxia-inducible
factor (HIF-1) and its relationship to apoptosis and proliferation
in lung cancer. Anticancer Res. 20:1527–1533. 2000.PubMed/NCBI
|
|
42
|
Ravi R, Mookerjee B, Bhujwalla ZM, Sutter
CH, Artemov D, Zeng Q, Dillehay LE, Madan A, Semenza GL and Bedi A:
Regulation of tumor angiogenesis by p53-induced degradation of
hypoxia-inducible factor 1alpha. Genes Dev. 14:34–44.
2000.PubMed/NCBI
|
|
43
|
Bruick RK: Expression of the gene encoding
the proapoptotic Nip3 protein is induced by hypoxia. Proc Natl Acad
Sci USA. 97:pp. 9082–9087. 2000; View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Graeber TG, Osmanian C, Jacks T, Housman
DE, Koch CJ, Lowe SW and Giaccia AJ: Hypoxia-mediated selection of
cells with diminished apoptotic potential in solid tumours. Nature.
379:88–91. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Semenza GL: Hypoxia, clonal selection, and
the role of HIF-1 in tumor progression. Crit Rev Biochem Mol Biol.
35:71–103. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Reynolds TY, Rockwell S and Glazer PM:
Genetic instability induced by the tumor microenvironment. Cancer
Res. 56:5754–5757. 1996.PubMed/NCBI
|
|
47
|
Sendoel A, Kohler I, Fellmann C, Lowe SW
and Hengartner MO: HIF-1 antagonizes p53-mediated apoptosis through
a secreted neuronal tyrosinase. Nature. 465:577–583. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Bindra RS and Glazer PM: Genetic
instability and the tumor microenvironment: Towards the concept of
microenvironment-induced mutagenesis. Mutat Res. 569:75–85. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Clevers H: The cancer stem cell: Premises,
promises and challenges. Nat Med. 17:313–319. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Visvader JE and Stingl J: Mammary stem
cells and the differentiation hierarchy: Current status and
perspectives. Genes Dev. 28:1143–1158. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Oskarsson T, Batlle E and Massagué J:
Metastatic stem cells: Sources, niches, and vital pathways. Cell
Stem Cell. 14:306–321. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Velasco-Velázquez MA, Popov VM, Lisanti MP
and Pestell RG: The role of breast cancer stem cells in metastasis
and therapeutic implications. Am J Pathol. 179:2–11. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Keith B and Simon MC: Hypoxia-inducible
factors, stem cells, and cancer. Cell. 129:465–472. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Conley SJ, Gheordunescu E, Kakarala P,
Newman B, Korkaya H, Heath AN, Clouthier SG and Wicha MS:
Antiangiogenic agents increase breast cancer stem cells via the
generation of tumor hypoxia. Proc Natl Acad Sci USA. 109:pp.
2784–2789. 2012; View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Mathieu J, Zhang Z, Nelson A, Lamba DA,
Reh TA, Ware C and Ruohola-Baker H: Hypoxia induces re-entry of
committed cells into pluripotency. Stem Cells. 31:1737–1748. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Zhang C, Samanta D, Lu H, Bullen JW, Zhang
H, Chen I, He X and Semenza GL: Hypoxia induces the breast cancer
stem cell phenotype by HIF-dependent and ALKBH5-mediated
m6A-demethylation of NANOG mRNA. Proc Natl Acad Sci USA. 113:pp.
E2047–E2056. 2016; View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Muñoz-Nájar UM, Neurath KM, Vumbaca F and
Claffey KP: Hypoxia stimulates breast carcinoma cell invasion
through MT1-MMP and MMP-2 activation. Oncogene. 25:2379–2392. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Krishnamachary B, Zagzag D, Nagasawa H,
Rainey K, Okuyama H, Baek JH and Semenza GL: Hypoxia-inducible
factor-1-dependent repression of E-cadherin in von Hippel-Lindau
tumor suppressor-null renal cell carcinoma mediated by TCF3,
ZFHX1A, and ZFHX1B. Cancer Res. 66:2725–2731. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Lester RD, Jo M, Montel V, Takimoto S and
Gonias SL: uPAR induces epithelial-mesenchymal transition in
hypoxic breast cancer cells. J Cell Biol. 178:425–436. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Semenza GL: The hypoxic tumor
microenvironment: A driving force for breast cancer progression.
Biochim Biophys Acta. 1863:382–391. 2016. View Article : Google Scholar : PubMed/NCBI
|
